179 related articles for article (PubMed ID: 26446694)
21. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer.
Duncan JR; Carr D; Kaffenberger BH
J Am Acad Dermatol; 2016 Jul; 75(1):186-96. PubMed ID: 26992283
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
[TBL] [Abstract][Full Text] [Related]
23. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
24. Imaging of Merkel Cell Carcinoma: What Imaging Experts Should Know.
Akaike G; Akaike T; Fadl SA; Lachance K; Nghiem P; Behnia F
Radiographics; 2019; 39(7):2069-2084. PubMed ID: 31697628
[TBL] [Abstract][Full Text] [Related]
25. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
Ishiyama M; Behnia F; Vesselle H
AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
[No Abstract] [Full Text] [Related]
26. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.
Peloschek P; Novotny C; Mueller-Mang C; Weber M; Sailer J; Dawid M; Czerny C; Dudczak R; Kletter K; Becherer A
Eur J Radiol; 2010 Feb; 73(2):317-23. PubMed ID: 19108971
[TBL] [Abstract][Full Text] [Related]
27. High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.
Hofman MS; Kong G; Neels OC; Eu P; Hong E; Hicks RJ
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):40-7. PubMed ID: 22339744
[TBL] [Abstract][Full Text] [Related]
28. Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients.
Maury G; Dereure O; Du-Thanh A; Mariano-Goulart D; Guillot B
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1420-7. PubMed ID: 21366705
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
[TBL] [Abstract][Full Text] [Related]
30. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
[TBL] [Abstract][Full Text] [Related]
31. Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma.
Zijlker LP; Bakker M; van der Hiel B; Bruining A; Klop WMC; Zuur CL; Wouters MWJM; van Akkooi ACJ
J Surg Oncol; 2023 Apr; 127(5):841-847. PubMed ID: 36573839
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
34. Complementary role of positron emission tomography in merkel cell carcinoma.
Lin O; Thomas A; Singh A; Greenspan B
South Med J; 2004 Nov; 97(11):1110-2. PubMed ID: 15586604
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J
Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Amal G; Sara T; Ghofrane CS; Malika AI; Majdouline H; Souha S; Abdelatif B; Najoua T; Ghita B; Zineb B; Nabil C
Pan Afr Med J; 2016; 23():156. PubMed ID: 27303574
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
38. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
39. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity.
Gardair C; Samimi M; Touzé A; Coursaget P; Lorette G; Caille A; Wierzbicka E; Croué A; Avenel-Audran M; Aubin F; Kerdraon R; Estève E; Beneton N; Guyétant S
Neuroendocrinology; 2015; 101(3):223-35. PubMed ID: 25765179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
